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The case of a girl with recurring chorea and a Takayasu’s arteritis diagnosis is reported.
This  clinical manifestation has been reported in only one patient with this vasculitis in the
pediatric group.
© 2013 Elsevier Editora Ltda. All rights reserved.
Coreia:  uma  manifestac¸ão rara  da  arterite  de  Takayasu
Palavras-chave:
r  e  s  u  m  o
Relatamos um caso de uma menina com coreia recorrente e diagnóstico de arterite de
Vasculite
Arterite de Takayasu
Coreia
Sintomas neurológicos
Crianc¸a
Takayasu. Esta manifestac¸ão clínica foi relatada em apenas um paciente com tal vasculite
na  faixa etária pediátrica.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.IntroductionTakayasu’s arteritis (TA) is a chronic inﬂammatory disease
with an unknown etiology, affecting the aorta and its major
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2255-5021/© 2013 Elsevier Editora Ltda. All rights reserved.branches, as well as the pulmonary artery.1 It is a rare disease,
especially in childhood, with pediatric patients corresponding
to 20% of cases.2 In the pediatric population, symptoms are
insidious and systemic manifestations, such as fever, weight
loss, and musculoskeletal symptoms predominate early in the
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isease, which contributes to a longer time elapsed before the
iagnosis is made in younger patients.3,4
Hypertension is the main clinical ﬁnding of the disease in
hildhood and other ﬁndings include bruits, diminished or
bsent pulses, difference of blood pressure between limbs,
eart failure, and claudication.4,5 Central nervous system
CNS) manifestations are common in the pediatric population
nd might include headaches, dizziness, syncope, visual loss,
eizures, and stroke.2,3,6
Many  studies highlight an association of chorea with
utoimmune rheumatic diseases, such as rheumatic
ever, systemic lupus erythematosus, and antiphospho-
ipid syndrome.7–10 Reports on the association of chorea
ith Behcet’s disease and Churg-Strauss syndrome have also
een found.11,12 However, only one case of chorea has been
escribed in a child with Takayasu’s arteritis.13
As this is a rare disease and only one case of chorea is
eported in pediatric patients with this vasculitis, we  describe
he case of a child with TA manifesting chorea in the onset of
he disease and over its course.
ase  report
 10-year-old girl started presenting with a daily pain in the
ands and lower limbs since she was 4. The pain was more
ften felt late in the afternoon, worse in cold climate and
hen exercising and was improved with rest. Swelling and
ever were not present. Two years after the onset of the condi-
ion, the painful symptoms were maintained and the patient
tarted presenting involuntary movements on the left side of
er body, which was worse with stress and improved dur-
ng sleep. Chorea was diagnosed and its cause remained to
e determined by the neurologist, who prescribed haloperi-
ol (0.5 mg/day), with improvement of the condition after the
edication was used for 1 week. Brain magnetic resonance
maging was normal and the EEG showed a posterior temporal
nd right occipital paroxysmal activity.
The patient remained asymptomatic for 2 years and then a
aily headache and hypertension were found and thus she
as referred to a cardiologist. A difference in blood pres-
ure between the arms was present, blood pressure was not
bservable in both lower limbs, in addition to absent femoral,
opliteal, pedal, and posterior tibial pulses. She underwent
n angiography which showed severe coarctation of the des-
ending aorta. The echocardiography showed a mild tricuspid
egurgitation. Captopril and propranolol were prescribed and
he patient was referred to the department of pediatric
heumatology with an initial diagnosis of rheumatic fever
r TA. At the ﬁrst visit to the pediatric rheumatology clinic,
aboratory analyses showed slight elevation in inﬂammatory
ctivity tests (erythrocyte sedimentation rate, and C-reactive
rotein) and absence of antinuclear antibody, anti-DNA, anti-
odies to extractable nuclear antigens, anticardiolipin, and
ntineutrophil cytoplasmic antibodies. TA was diagnosed
nd methotrexate 0.6 mg/kg/week, folic acid, amlodipine, and
spirin at antiaggregant dosage were introduced. She received
 methylprednisolone IV pulses (30 mg/kg) and captopril,
ropranolol, and haloperidol were maintained. One month
ater, chorea recurred and then a penicillin G benzathine 5;5 5(4):384–386 385
prophylaxis (1.2 milion units IMq3wk) was initiated. Six
months later, an onset of right ankle, knee, and wrist arthritis,
claudication, and headache was observed. At that time, a renal
Doppler ultrasound showed >50% stenosis in the abdominal
aorta above the kidneys and a <50% stenosis below the renal
arteries emergence. Magnetic resonance angiogram showed
infrarenal aorta and common iliac artery narrowing. Due
to the major vascular impairment, cyclophosphamide was
added into the pulse methylprednisolone therapy. One month
later, haloperidol was withdrawn because of the absence of
neurological symptoms (the treatment had been used for two
and a half years). At the fourth cycle of cyclophosphamide, 3
months after haloperidol had been withdrawn, chorea reap-
peared for the third time and haloperidol was reintroduced
(1 mg/day).
The patient currently maintains a visual blurring, ankle
joint pain, long-distance claudication, and dyspnea on exer-
tion. Blood pressure is controlled (by three antihypertensive
drugs) and the patient had a slight improvement in lower-
limb pulse amplitude. Following an 8-month treatment for
chorea, the neurologist stopped the haloperidol and the
patient has had no chorea for 1 year since the last recurrence.
Inﬂammatory tests were normal. A new echocardiogram
showed segmental coarctation of the low aortic arch with
hemodynamic repercussion and mild concentric left ventri-
cle hypertrophy. Following seven cyclophosphamide (1 g/m2)
infusions, the patient maintained the complaints and a brain
magnetic resonance angiogram showed an internal carotid
artery stenosis. As a result, we decided to start inﬂiximab
(5 mg/kg). As the chorea was suggested to be associated with
Takayasu’s, we chose to stop the penicillin G benzathine pro-
phylaxis. The patient is currently on methotrexate, folic acid,
amlodipine, captopril, propranolol, aspirin, ranitidine, and
inﬂiximab. She has been clinically better on inﬂiximab for 8
months, still presenting dyspnea on exertion, but the arthral-
gia and the visual blurring have improved.
Discussion
We  have reported the case of a 10-year-old girl with recurring
episodes of chorea associated with hypertension, diminished
peripheral pulses, and an angiogram consistent with TA. Other
rheumatic and nonrheumatic causes of chorea were ruled out.
The patient met  the validated classiﬁcation criteria for
childhood TA,14 which included angiographic abnormalities
associated with hypertension, a difference in blood pressure
between the limbs, diminished peripheral pulses, and claudi-
cation. The penicillin G benzathine prophylaxis was chosen at
ﬁrst because rheumatic fever is still the most common cause
of chorea in childhood,15 although the patient did not meet the
criteria for the disease. The youngest had two more episodes
of chorea in evolution, and one of the recurrences came off
when the girl was in use of haloperidol, and the other when in
secondary prophylaxis with penicillin benzathine, with ques-
tioning of the diagnosis of rheumatic fever.Our patient presented left hemibody recurring chorea. This
manifestation ceased only after a long immunosuppressive
treatment. At that time, other causes of chorea were inves-
tigated. Brain magnetic resonance imaging and EEG had no
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abnormal ﬁndings, which ruled other neurological causes out.
Thyrotoxicosis, also a cause for chorea, was ruled out. Nega-
tive antinuclear antibodies and antiphospholipid antibodies
ruled out the diagnosis of systemic lupus erythematosus
and the antiphospholipid syndrome as possible causes of
chorea. The patient did not have clinical manifestations con-
sistent with other primary vasculitides, such as Behcet’s
disease or polyarteritis nodosa. The most important differen-
tial diagnosis was rheumatic fever, but this assumption was
unlikely because of the absence of other major criteria, such
as carditis or arthritis early in the course, recurrence while
on penicillin G benzathine prophylaxis and improvement
from continuous immunosuppressive treatment. Constitu-
tional symptoms and acute phase nonspeciﬁc signs may be
common to both rheumatic fever and Takayasu’s arteritis,
however more  unique ﬁndings, such as diminished periph-
eral pulses, hypertension and a difference in BP between the
arms, in addition to imaging showing involvement of the aorta
and its branches, led to the diagnosis of Takayasu’s arteritis.
In addition, the patient has been out of streptococcal infec-
tion prophylaxis for 18 months and no other chorea episodes
occurred.
In the Brazilian multicenter study of 71 children and ado-
lescents with Takayasu arteritis published this year, more
than 70% of patients had neurological symptoms early in the
disease.16 These symptoms were represented by headache,
convulsions, fainting and stroke. There was no description of
chorea, except in the patient reported in this article.
The case of a child with TA presenting as a hemichorea has
been recently published in a Spanish report.13 Yet, no other
reports were published.
Antibodies to basal ganglia, in addition to the presence of
T lymphocytes, leading to an altered immune cell response,
would possibly explain the occurrence of this rare manifes-
tation. Furthermore, the involvement of intracranial vessels
could lead to hypoperfusion of brain areas, especially the basal
ganglia, and chorea emergence.
Through this case, we want to draw attention to a rare TA
manifestation. The physician should be alert to atypical man-
ifestations of the disease so that diagnosis and treatment are
promptly accomplished.Conﬂicts  of  interest
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